Hpv

Cervical Cancer Awareness Month is observed every January.

Expanding the current HPV vaccination program in the United States to include men and women up to age 45 years may only produce small additional benefits and is not nearly as cost-effective as it is among younger age groups, according to a study published in the Annals of Internal Medicine.

An increase in female HPV vaccination in the United States appears to have provided unvaccinated men aged 18 to 59 years herd protection against vaccine-type oral HPV infections, according to findings published today in JAMA. No such herd protection was recorded among unvaccinated women.

CDC data showed that most of the estimated 34,800 cancers yearly attributed to HPV annually between 2012 and 2016 could have been prevented if the patient had received the 9-valent HPV vaccine.

Some parents of adolescent boys are concerned about infertility as an adverse effect of the HPV vaccine, which may contribute to low vaccination rates in males, according to a paper presented at the 2013 Meeting of the Society for Adolescent Health and Medicine.